XENE
Xenon Pharmaceuticals Inc
36.90$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | +198.1% | -100.0% | – | – | – | – | – | |
| – | -50.9% | -29.6% | +10.0% | +1.5% | -5.4% | – | – | +12,092.1% | -99.2% | -3.9% | – | – | |
| – | – | -113.2% | – | – | – | +496.2% | -108.4% | – | – | – | – | – | |
| – | -4.2% | +7.7% | +12.3% | +14.6% | +4.4% | +2.9% | +22.5% | +2.8% | +13.8% | +0.9% | +12.1% | – | |
| – | -1.4% | +17.2% | +31.2% | -13.9% | +7.8% | +5.7% | +1.1% | +0.2% | +14.4% | +7.9% | +0.5% | – | |
| – | -3.6% | +8.8% | +18.2% | +6.6% | +5.2% | +3.6% | +16.6% | -79.4% | +466.1% | +2.9% | +9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -180.8% | – | – | – | -246.6% | – | -20.5% | -577.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.